The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
Open accessAbstract
We have identified and purified a novel cytokine, NK cell stimulatory factor (NKSF), from the cell-free supernatant fluid of the phorbol diester-induced EBV-transformed human B lymphoblastoid cell line RPMI 8866. NKSF activity is mostly associated to a 70-kD anionic glycoprotein. The purified 70-kD protein, isolated from an SDS-PAGE gel, yields upon reduction two small species of molecular masses of 40 and 35 kD, suggesting that this cytokine is a heterodimer. When added to human PBL, purified NKSF preparations induce IFN-gamma production and synergize with rIL-2 in this activity, augment the NK cell-mediated cytotoxicity of PBL preparations against both NK-sensitive and NK-resistant target cell lines, and enhance the mitogenic response of T cells to mitogenic lectins and phorbol diesters. The three activities remain associated through different purification steps resulting in a 9,200-fold purification, and purified NKSF mediates the three biological activities at concentrations in the range of 0.1-10 pM. These data strongly suggest that the same molecule mediates these three activities, although the presence of traces of contaminant peptides even in the most purified NKSF preparations does not allow us to exclude the possibility that distinct biologically active molecules have been co-purified. The absence of other known cytokines in the purified NKSF preparations, the unusual molecular conformation of NKSF, the high specific activity of the purified protein, and the spectrum of biological activities distinguish NKSF from other previously described cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Interleukin-2 augments natural killer cell activity
Henney, C. S., Kuribayashi, K., Kern, D. E., & Gillis, S. (1981) · Nature · doi:10.1038/291335a0 · Cited by 913
Trinchieri, G., & Santoli, D. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1314 · Cited by 733
Self-citationResponse of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
Self-citationCuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., & Trinchieri, G. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1581 · Cited by 360
Self-citationGarman, R. D., Jacobs, K. A., Clark, S. C., & Raulet, D. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7629 · Cited by 349
Self-citationLymphokine-activated killer cells: A new approach to immunotherapy of cancer
(1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/75.4.595 · Cited by 308
Ortaldo, J. R., Mason, A. T., Gerard, J. P., et al. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.2.779 · Cited by 307
Cited by
Items 101–163 of 163
Interferon-γ and interleukin-12 pathway defects and human disease
Dorman, S. E., & Holland, S. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00010-1 · Cited by 336
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
Beyond phytohaemagglutinin: assessing vertebrate immune function across ecological contexts
Demas, G. E., Zysling, D. A., Beechler, B. R., Muehlenbein, M. P., & French, S. S. (2011) · Journal of Animal Ecology · doi:10.1111/j.1365-2656.2011.01813.x · Cited by 334
NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury
Li, L., Huang, L., Sung, S.-S. J., Lobo, P. I., Brown, M. G., Gregg, R. K., Engelhard, V. H., & Okusa, M. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5899 · Cited by 331
Radstake, T. R. D. J., Roelofs, M. F., Jenniskens, Y. M., Oppers‐Walgreen, B., van Riel, P. L. C. M., Barrera, P., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20678 · Cited by 331
Hayes, M., Wang, J., & Norcross, M. (1995) · Blood · doi:10.1182/blood.v86.2.646.bloodjournal862646 · Cited by 329
Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C., Vainchenker, W., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0380 · Cited by 326
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Self-citationIdentification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells
Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700499200 · Cited by 319
Regulation of human cytolytic lymphocyte responses by interleukin-12
Gately, M. K., Wolitzky, A. G., Quinn, P. M., & Chizzonite, R. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90011-d · Cited by 321
Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., & Sacks, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.515 · Cited by 315
The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W. H., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 313
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311
Leung, D. Y., Gately, M., Trumble, A., Ferguson-Darnell, B., Schlievert, P. M., & Picker, L. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.747 · Cited by 307
Gerosa, F., Paganin, C., Peritt, D., Paiola, F., Scupoli, M. T., Aste-Amezaga, M., Frank, I., & Trinchieri, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2559 · Cited by 306
Self-citationCooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Cousens, L. P., Orange, J. S., Su, H. C., & Biron, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.634 · Cited by 304
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
NKT cells — conductors of tumor immunity?
Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., & Godfrey, D. I. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00316-3 · Cited by 294
Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.927 · Cited by 294
Zhang, L., Kerkar, S. P., Yu, Z., Zheng, Z., Yang, S., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2011) · Molecular Therapy · doi:10.1038/mt.2010.313 · Cited by 293
Immunoregulation by interleukin-12
Trinchieri, G., & Gerosa, F. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.505 · Cited by 291
Self-citationProinflammatory and Immunoregulatory Functions of Interleukin-12
Trinchieri, G. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043002 · Cited by 290
Self-citationBiologic functions of the IFN‐γ receptors
Tau, G., & Rothman, P. (1999) · Allergy · doi:10.1034/j.1398-9995.1999.00099.x · Cited by 288
Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., & Germann, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240403 · Cited by 287
Aliberti, J. C., Cardoso, M. A., Martins, G. A., Gazzinelli, R. T., Vieira, L. Q., & Silva, J. S. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.1961-1967.1996 · Cited by 286
Grohmann, U., Belladonna, M. L., Bianchi, R., Orabona, C., Ayroldi, E., Fioretti, M. C., & Puccetti, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80614-7 · Cited by 283
Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C., & Stallmach, A. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00003 · Cited by 280
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
Gerosa, F., Baldani-Guerra, B., Lyakh, L. A., Batoni, G., Esin, S., Winkler-Pickett, R. T., Consolaro, M. R., De Marchi, M., Giachino, D., Robbiano, A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071450 · Cited by 280
Self-citationThe interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer
Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rüde, E., & Germann, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230923 · Cited by 279
Debarry, J., Garn, H., Hanuszkiewicz, A., Dickgreber, N., Blümer, N., von Mutius, E., Bufe, A., Gatermann, S., Renz, H., Holst, O., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.023 · Cited by 279
Rook, A. H., Wood, G. S., Yoo, E. K., Elenitsas, R., Kao, D. M. F., Sherman, M. L., Witmer, W. K., Rockwell, K. A., Shane, R. B., Lessin, S. R., et al. (1999) · Blood · doi:10.1182/blood.v94.3.902.415k23_902_908 · Cited by 277
The human model: a genetic dissection of immunity to infection in natural conditions
Casanova, J.-L., & Abel, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1264 · Cited by 277
Wale, M. K. T. Ć., Holt, P. G., & Sly, P. D. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.5.3710 · Cited by 276
Finkelman, F. D., Madden, K. B., Cheever, A. W., Katona, I. M., Morris, S. C., Gately, M. K., Hubbard, B. R., Gause, W. C., & Urban, J. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1563 · Cited by 273
Murosaki, S., Yamamoto, Y., Ito, K., Inokuchi, T., Kusaka, H., Ikeda, H., & Yoshikai, Y. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70055-7 · Cited by 272
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
Ma, X., Yan, W., Zheng, H., Du, Q., Zhang, L., Ban, Y., Li, N., & Wei, F. (2015) · F1000Research · doi:10.12688/f1000research.7010.1 · Cited by 272
Cardillo, F., Voltarelli, J. C., Reed, S. G., & Silva, J. S. (1996) · Infection and Immunity · doi:10.1128/iai.64.1.128-134.1996 · Cited by 271
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Interleukin‐12 production by human polymorphonuclear leukocytes
Cassatella, M. A., Meda, L., Gasperini, S., D'Andrea, A., Ma, X., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250102 · Cited by 269
Self-citationThe role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy.
Naseer, T., Minshall, E. M., Leung, D. Y., Laberge, S., Ernst, P., Martin, R. J., & Hamid, Q. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117015 · Cited by 267
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Verstockt, B., Salas, A., Sands, B. E., Abraham, C., Leibovitzh, H., Neurath, M. F., Vande Casteele, N., Alimentiv Translational Research Consortium (ATRC), Danese, S., D’Haens, G., et al. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00768-1 · Cited by 261
Interleukin‐35: odd one out or part of the family?
Collison, L. W., & Vignali, D. A. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00704.x · Cited by 260
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Kerkar, S. P., Muranski, P., Kaiser, A., Boni, A., Sanchez-Perez, L., Yu, Z., Palmer, D. C., Reger, R. N., Borman, Z. A., Zhang, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0735 · Cited by 254
Self-citationWang, K. S., Frank, D. A., & Ritz, J. (2000) · Blood · doi:10.1182/blood.v95.10.3183 · Cited by 241
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
Boniface, K., Blom, B., Liu, Y., & De Waal Malefyt, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00714.x · Cited by 218
“In our initial characterization of the effects of IL-23 on human T cells, we compared the activities of IL-23 and IL-12 on the proliferation and IFN-g production by 7-day-old PHA blasts, a classical bioassay for IL-12 activity (12).”
BackgroundMethodKatiyar, S. K., Challa, A., McCormick, T. S., Cooper, K. D., & Mukhtar, H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2117 · Cited by 193
Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187
Self-citationGlassman, C. R., Mathiharan, Y. K., Jude, K. M., Su, L., Panova, O., Lupardus, P. J., Spangler, J. B., Ely, L. K., Thomas, C., Skiniotis, G., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.018 · Cited by 181
Molecular basis of the cell specificity of cytokine action
Ishihara, K., & Hirano, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00321-x · Cited by 122
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105
Self-citationBlockade of IL-23: What is in the Pipeline?
Parigi, T. L., Iacucci, M., & Ghosh, S. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab185 · Cited by 93
Duan, X., Guan, H., Cao, Y., & Kleinerman, E. S. (2009) · Cancer · doi:10.1002/cncr.24013 · Cited by 79
Kitaura, H., Nagata, N., Fujimura, Y., Hotokezaka, H., Yoshida, N., & Nakayama, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4732 · Cited by 72
“Target cells for IL-12 have been reported to include T cells (21–25), NK cells (21, 22, 46), NKT cells (47), B cells (52), dendritic cells (53), and macrophages (54).”
Background(2003) · PubMed · Cited by 67
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
Cacemiro, M. D. C., Cominal, J. G., Tognon, R., Nunes, N. D. S., Simões, B. P., Figueiredo-Pontes, L. L. D., Catto, L. F. B., Traina, F., Souto, E. X., Zambuzi, F. A., et al. (2018) · Hematology, Transfusion and Cell Therapy · doi:10.1016/j.htct.2017.12.003 · Cited by 55
Gasparri, A. M., Sacchi, A., Basso, V., Cortesi, F., Freschi, M., Rrapaj, E., Bellone, M., Casorati, G., Dellabona, P., Mondino, A., et al. (2019) · Small · doi:10.1002/smll.201903462 · Cited by 37
Pizzoferrato, E., Chu, N. R., Hawley, T. S., Lieu, F. H. L., Barber, B. H., Hawley, R. G., Watts, T. H., & Berinstein, N. L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.18-2217 · Cited by 28
Trinchieri, G. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470514849.ch14 · Cited by 23
Self-citation
Metadata
- Authors
- Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1989-09-01
- Volume
- 170
- Issue
- 3
- Pages
- 827-845
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2102156468
- Cited by
- 1,953
- References
- 32
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.